These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2587937)

  • 41. HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus. Studies of healthy individuals and patients with type 1 diabetes.
    Bruserud O; Thorsby E
    Scand J Immunol; 1985 Nov; 22(5):509-18. PubMed ID: 2417308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of HLA class II products in proliferative T-lymphocyte responses to PPD. Evidence of a regulatory influence associated with MB1.
    van Eden W; Elferink BG; Hermans J; de Vries RR; van Rood JJ
    Scand J Immunol; 1984 Dec; 20(6):503-10. PubMed ID: 6083600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accessory signals in T-T cell interactions between antigen- and alloantigen-specific, human memory T cells generated in vitro.
    Odum N; Ryder LP; Georgsen J; Jakobsen BK; Geisler C; Møller J; Morling N; Dickmeiss E; Svejgaard A
    Scand J Immunol; 1990 Jun; 31(6):717-28. PubMed ID: 2162555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
    Michelsen B; Lernmark A
    J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
    Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restriction molecules involved in the interaction of human T cell clones with antigen-presenting cells.
    Koide Y; Yoshida TO
    Immunol Lett; 1984; 7(4):209-13. PubMed ID: 6200432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP; DeMars R; Hank JA; Sondel PM
    Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E; Umetsu D; Rosen F; Geha RS
    J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-D/DR restriction of Langerhans cell-dependent antigen activation of T lymphocytes. The same D/DR determinants are restriction elements on monocytes and Langerhans cells.
    Berle EJ; Braathen LR; Thorsby E
    Scand J Immunol; 1982 Dec; 16(6):549-52. PubMed ID: 6186017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes.
    Monetini L; Barone F; Stefanini L; Petrone A; Walk T; Jung G; Thorpe R; Pozzilli P; Cavallo MG
    J Endocrinol; 2003 Jan; 176(1):143-50. PubMed ID: 12525258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serological and biological cross-reactivity of class II antigens between mice and humans in antigen-specific T-cell proliferative responses.
    Yamamoto M; Yano A
    Cell Immunol; 1984 Sep; 87(2):659-73. PubMed ID: 6331900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T lymphocyte responses to Coxsackie B4 and mumps virus. I. Influence of HLA-DR restriction elements.
    Bruserud O; Thorsby E
    Tissue Antigens; 1985 Jul; 26(1):41-50. PubMed ID: 2994251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.
    Woo J; Propper DJ; Thomson AW
    Immunology; 1990 Dec; 71(4):551-5. PubMed ID: 1703987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of HLA-DR antigens in PPD-stimulated lymphocyte-monocyte interactions.
    Haar D; Heron I
    Scand J Immunol; 1982 Nov; 16(5):403-11. PubMed ID: 6184773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth of antigen specific, HLA restricted T lymphocyte clones from cerebrospinal fluid.
    Fleischer B; Bogdahn U
    Clin Exp Immunol; 1983 Apr; 52(1):38-44. PubMed ID: 6190597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
    Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
    J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes.
    Rharbaoui F; Mayer A; Granier C; Bouanani M; Thivolet C; Pau B; Orgiazzi J; Madec AM
    Clin Exp Immunol; 1999 Jul; 117(1):30-7. PubMed ID: 10403912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amplification of T-cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes.
    Tjernlund U; Scheynius A
    Scand J Immunol; 1987 Jul; 26(1):1-6. PubMed ID: 2441455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.